A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China
Beijing Health Guard Biotechnology, Inc
Beijing Health Guard Biotechnology, Inc
Alliance for Clinical Trials in Oncology
INSYS Therapeutics Inc
National Cancer Institute (NCI)